Pancreatic cancer study aims to match treatments to tumor genetics
NCT ID NCT05914987
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at medical records from 1,000 adults with pancreatic cancer to see if treatments chosen based on each tumor's genetic profile lead to better results. Researchers will track how many patients receive a genetically matched therapy and how well they respond. The goal is to learn whether personalized treatment can improve survival and reduce side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Froedtert Hospital and the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?